AND EXCHANGE COMMISSION
to Section 13 or 15(d) of the Securities Exchange Act of
Report (date of earliest event reported): October 16, 2009
Medical Holdings, Inc.
Name of Registrant as Specified in its Charter)
or Other Jurisdiction
N Central Avenue
of Principal Executive Offices)
Name or Former Address, if Changed Since Last Report)
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425).
material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12).
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b)).
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c)).
amended Current Report on Form 8-K/A (the “8-K/A”) is being filed in order to
correct a misstatement in registrant’s Current Report on Form 8-K filed on
October 19, 2009 (the “Original 8-K”)
relating to the number of warrants issued to Syndicated Capital, Inc., a FINRA
member firm that acted as placement agent (the “Placement Agent”) in
connection with the private placement transaction reported in the Original 8-K
Original 8-K incorrectly disclosed that in connection with the Private Placement
the Placement Agent received five-year warrants to purchase up to 150,000 shares
of the Common Stock at an initial exercise price per share of
$0.25. However, the Placement Agent actually received five-year
warrants to purchase up to 250,000 shares of the Common Stock at an initial
exercise price of $0.25 per share of Common Stock.
for the correction herein as to the number of warrants issued to the Placement
Agent in the Private Placement, this 8-K/A does not amend or update any other
information contained in the Original 8-K.
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this Report to be signed on its behalf by the undersigned hereunto
MEDICAL HOLDINGS, INC.
A. NOEL DEWINTER